Productivity trends and collaboration patterns: A diachronic study in the eating disorders field

[EN] Objective The present study seeks to extend previous bibliometric studies on eating disorders (EDs) by including a time-dependent analysis of the growth and evolution of multi-author collaborations and their correlation with ED publication trends from 1980 to 2014 (35 years). Methods Using standardized practices, we searched Web of Science (WoS) Core Collection (WoSCC) (indexes: Science Citation Index-Expanded [SCIE], & Social Science Citation Index [SSCI]) and Scopus (areas: Health Sciences, Life Sciences, & Social Sciences and Humanities) to identify a large sample of articles related to EDs. We then submitted our sample of articles to bibliometric and graph theory analyses to identify co-authorship and social network patterns. Results We present a large number of detailed findings, including a clear pattern of scientific growth measured as number of publications per five-year period or quinquennium (Q), a tremendous increase in the number of authors attracted by the ED subject, and a very high and steady growth in collaborative work. Conclusions We inferred that the noted publication growth was likely driven by the noted increase in the number of new authors per Q. Social network analyses suggested that collaborations within ED follow patters of interaction that are similar to well established and recognized disciplines, as indicated by the presence of a ¿giant cluster¿, high cluster density, and the replication of the ¿small world¿ phenomenon¿the principle that we are all linked by short chains of acquaintances.This work was performed with a subsidy from Universidad Catolica de Valencia "San Vicente Martir" to resarch group INDOTEI: Evaluacion de la Ciencia, for the years 2016-2017. This work is benefited from Spanish Government assistance through Government Delegation for the National Drugs Plan of the Ministry of Health, Social Services and Equality (project 2016/028); and National R+D+I (projects: CS02012-39632-C02-01 and CS02015-65594-C2-2-R) and 2015-Networks of Excellence Call (project CS02015-71867-REDT) of the Ministry of Economy and Competitiveness.Valderrama Zurian, JC.; Aguilar-Moya, R.; Cepeda-Benito, A.; Melero-Fuentes, D.; Navarro-Moreno, MÁ.; Gandía-Balaguer, A.; Aleixandre-Benavent, R. (2017). Productivity trends and collaboration patterns: A diachronic study in the eating disorders field. PLoS ONE. 12(8):1-17. https://doi.org/10.1371/journal.pone.0182760S117128McClelland, J., Bozhilova, N., Campbell, I., & Schmidt, U. (2013). A Systematic Review of the Effects of Neuromodulation on Eating and Body Weight: Evidence from Human and Animal Studies. European Eating Disorders Review, 21(6), 436-455. doi:10.1002/erv.2256Lancelot, C., Brooks-Gunn, J., Warren, M. P., & Newman, D. L. (1991). Comparison of DSM-III and DSM-III-R bulimia nervosa classifications for psychopathology and other eating behaviors. International Journal of Eating Disorders, 10(1), 57-66. doi:10.1002/1098-108x(199101)10:13.0.co;2-tWONDERLICH, S. A., CROSBY, R. D., JOINER, T., PETERSON, C. B., BARDONE-CONE, A., KLEIN, M., … VRSHEK, S. (2005). Personality subtyping and bulimia nervosa: psychopathological and genetic correlates. Psychological Medicine, 35(5), 649-657. doi:10.1017/s0033291704004234Spitzer, R. L., Devlin, M. J., Walsh, B. T., Hasin, D., Wing, R., Marcus, M. D., … Nonas, C. (1991). Binge eating disorder: To be or not to be in DSM-IV. International Journal of Eating Disorders, 10(6), 627-629. doi:10.1002/1098-108x(199111)10:63.0.co;2-4Wonderlich, S. A., Gordon, K. H., Mitchell, J. E., Crosby, R. D., & Engel, S. G. (2014). The Validity and Clinical Utility of Binge Eating Disorder. FOCUS, 12(4), 489-505. doi:10.1176/appi.focus.120412Theander, S. S. (2002). Literature on eating disorders during 40 Years: increasing number of papers, emergence of bulimia nervosa. European Eating Disorders Review, 10(6), 386-398. doi:10.1002/erv.495Clinton, D. (2010). Towards an ecology of eating disorders: Creating sustainability through the integration of scientific research and clinical practice. European Eating Disorders Review, 18(1), 1-9. doi:10.1002/erv.986Soh, N. L.-W., & Walter, G. (2013). Publications on cross-cultural aspects of eating disorders. Journal of Eating Disorders, 1(1). doi:10.1186/2050-2974-1-4Wuchty, S., Jones, B. F., & Uzzi, B. (2007). The Increasing Dominance of Teams in Production of Knowledge. Science, 316(5827), 1036-1039. doi:10.1126/science.1136099Kumar, S. (2015). Co-authorship networks: a review of the literature. Aslib Journal of Information Management, 67(1), 55-73. doi:10.1108/ajim-09-2014-0116Barabási, A. ., Jeong, H., Néda, Z., Ravasz, E., Schubert, A., & Vicsek, T. (2002). Evolution of the social network of scientific collaborations. Physica A: Statistical Mechanics and its Applications, 311(3-4), 590-614. doi:10.1016/s0378-4371(02)00736-7Newman, M. E. J. (2004). Coauthorship networks and patterns of scientific collaboration. Proceedings of the National Academy of Sciences, 101(Supplement 1), 5200-5205. doi:10.1073/pnas.0307545100Aleixandre-Benavent, R., & Alonso-Arroyo, A. (2011). Indicadores bibliométricos, patología del aparato respiratorio y reducción del consumo de tabaco. Revista de Patología Respiratoria, 14(1), 1-3. doi:10.1016/s1576-9895(11)70095-9Pino-Díaz, J., Jiménez-Contreras, E., Ruíz-Baños, R., & Bailón-Moreno, R. (2011). Evaluación de redes tecnocientíficas: la red española sobre Áreas Protegidas, según la Web of Science. Revista española de Documentación Científica, 34(3), 301-333. doi:10.3989/redc.2011.3.804Valderrama-Zurián, J.-C., Aguilar-Moya, R., Melero-Fuentes, D., & Aleixandre-Benavent, R. (2015). A systematic analysis of duplicate records in Scopus. Journal of Informetrics, 9(3), 570-576. doi:10.1016/j.joi.2015.05.002Guardiola-Wanden-Berghe, R., Sanz-Valero, J., & Wanden-Berghe, C. (2012). Medical subject headings versus American Psychological Association Index Terms: indexing eating disorders. Scientometrics, 94(1), 305-311. doi:10.1007/s11192-012-0866-7Soh, N., Walter, G., Touyz, S., Russell, J., Malhi, G. S., & Hunt, G. E. (2012). Food for thought: Comparison of citations received from articles appearing in specialized eating disorder journals versus general psychiatry journals. International Journal of Eating Disorders, 45(8), 990-994. doi:10.1002/eat.22036Theander, S. S. (2004). Trends in the literature on eating disorders over 36 years(1965-2000): terminology, interpretation and treatment. European Eating Disorders Review, 12(1), 4-17. doi:10.1002/erv.559Kawamura, M., Thomas, C. D. L., Tsurumoto, A., Sasahara, H., & Kawaguchi, Y. (2000). Lotka’s law and productivity index of authors in a scientific journal. Journal of Oral Science, 42(2), 75-78. doi:10.2334/josnusd.42.75Lawani SM. Quality, collaboration and citations in cancer research: A bibliometric study. PhD thesis. Florida State University, Tallahassee. 1980.Watts, D. J., & Strogatz, S. H. (1998). Collective dynamics of ‘small-world’ networks. Nature, 393(6684), 440-442. doi:10.1038/30918Jacomy, M., Venturini, T., Heymann, S., & Bastian, M. (2014). ForceAtlas2, a Continuous Graph Layout Algorithm for Handy Network Visualization Designed for the Gephi Software. PLoS ONE, 9(6), e98679. doi:10.1371/journal.pone.0098679Pike, K. M., & Dunne, P. E. (2015). The rise of eating disorders in Asia: a review. Journal of Eating Disorders, 3(1). doi:10.1186/s40337-015-0070-2El Ghoch, M., Soave, F., Calugi, S., & Dalle Grave, R. (2013). Eating Disorders, Physical Fitness and Sport Performance: A Systematic Review. Nutrients, 5(12), 5140-5160. doi:10.3390/nu5125140Jones, A. W. (2007). The distribution of forensic journals, reflections on authorship practices, peer-review and role of the impact factor. Forensic Science International, 165(2-3), 115-128. doi:10.1016/j.forsciint.2006.05.013Baker, T., Hatsukami, D., Lerman, C., O’Malley, S., Shields, A., & Fiore, M. (2003). Transdisciplinary science applied to the evaluation of treatments for tobacco use. Nicotine & Tobacco Research, 5(6), 89-99. doi:10.1080/14622200310001625564González-Alcaide, G., Melero-Fuentes, D., Aleixandre-Benavent, R., & Valderrama-Zurián, J.-C. (2013). Productivity and Collaboration in Scientific Publications on Criminology. Journal of Criminal Justice Education, 24(1), 15-37. doi:10.1080/10511253.2012.664153López-Muñoz, F., Alamo, C., Rubio, G., García-García, P., Martín-Agueda, B., & Cuenca, E. (2003). Bibliometric analysis of biomedical publications on SSRI during 1980-2000. Depression and Anxiety, 18(2), 95-103. doi:10.1002/da.10121González-Alcaide, G., Aleixandre-Benavent, R., Navarro-Molina, C., & Valderrama-Zurián, J. C. (2008). Coauthorship networks and institutional collaboration patterns in reproductive biology. Fertility and Sterility, 90(4), 941-956. doi:10.1016/j.fertnstert.2007.07.1378González-Alcaide, G., Park, J., Huamaní, C., Belinchón, I., & Ramos, J. M. (2015). Evolution of Cooperation Patterns in Psoriasis Research: Co-Authorship Network Analysis of Papers in Medline (1942–2013). PLOS ONE, 10(12), e0144837. doi:10.1371/journal.pone.0144837Bordons, M., & Ángeles Zulueta, M. (2002). La interdisciplinariedad en los grupos españoles de investigación en el área cardiovascular. Revista Española de Cardiología, 55(9), 900-912. doi:10.1016/s0300-8932(02)76728-6Chan, H. F., Önder, A. S., & Torgler, B. (2015). The first cut is the deepest: repeated interactions of coauthorship and academic productivity in Nobel laureate teams. Scientometrics, 106(2), 509-524. doi:10.1007/s11192-015-1796-yBordons, M., Aparicio, J., González-Albo, B., & Díaz-Faes, A. A. (2015). The relationship between the research performance of scientists and their position in co-authorship networks in three fields. Journal of Informetrics, 9(1), 135-144. doi:10.1016/j.joi.2014.12.001Newman, M. E. J. (2001). The structure of scientific collaboration networks. Proceedings of the National Academy of Sciences, 98(2), 404-409. doi:10.1073/pnas.98.2.404Fatt, C. K., Ujum, E. A., & Ratnavelu, K. (2010). The structure of collaboration in the Journal of Finance. Scientometrics, 85(3), 849-860. doi:10.1007/s11192-010-0254-0Kretschmer, H. (2004). Author productivity and geodesic distance in bibliographic co-authorship networks, and visibility on the Web. Scientometrics, 60(3), 409-420. doi:10.1023/b:scie.0000034383.86665.22Yan, E., Ding, Y., & Zhu, Q. (2009). Mapping library and information science in China: a coauthorship network analysis. Scientometrics, 83(1), 115-131. doi:10.1007/s11192-009-0027-9Yin, L., Kretschmer, H., Hanneman, R. A., & Liu, Z. (2006). Connection and stratification in research collaboration: An analysis of the COLLNET network. Information Processing & Management, 42(6), 1599-1613. doi:10.1016/j.ipm.2006.03.021Lambiotte, R., & Panzarasa, P. (2009). Communities, knowledge creation, and information diffusion. Journal of Informetrics, 3(3), 180-190. doi:10.1016/j.joi.2009.03.007Leydesdorff, L. (2012). World shares of publications of the USA, EU-27, and China compared and predicted using the new Web of Science interface versus Scopus. El Profesional de la Informacion, 21(1), 43-49. doi:10.3145/epi.2012.ene.06Bartol, T., Budimir, G., Dekleva-Smrekar, D., Pusnik, M., & Juznic, P. (2013). Assessment of research fields in Scopus and Web of Science in the view of national research evaluation in Slovenia. Scientometrics, 98(2), 1491-1504. doi:10.1007/s11192-013-1148-8López-Illescas, C., de Moya-Anegón, F., & Moed, H. F. (2008). Coverage and citation impact of oncological journals in the Web of Science and Scopus. Journal of Informetrics, 2(4), 304-316. doi:10.1016/j.joi.2008.08.001Warren, C. S., Gleaves, D. H., Cepeda-Benito, A., Fernandez, M. del C., & Rodriguez-Ruiz, S. (2005). Ethnicity as a protective factor against internalization of a thin ideal and body dissatisfaction. International Journal of Eating Disorders, 37(3), 241-249. doi:10.1002/eat.20102Prince, R., & Thebaud, E. F. (1983). Is Anorexia Nervosa a Culture-Bound Syndrome? Transcultural Psychiatric Research Review, 20(4), 299-302. doi:10.1177/136346158302000419Miller, M. N., & Pumariega, A. J. (2001). Culture and Eating Disorders: A Historical and Cross-Cultural Review. Psychiatry: Interpersonal and Biological Processes, 64(2), 93-110. doi:10.1521/psyc.64.2.93.1862

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3

ObjectivesCARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain.MethodsIn total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC &gt; 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis.ResultsIn total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were blaOXA–48 (263/377), blaKPC–3 (62/377), blaVIM–1 (28/377), and blaNDM–1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5).ConclusionThis study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3

Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists

Vitamin K antagonist (VKA) therapy for stroke prevention in atrial fibrillation (AF) requires monitoring of the international normalized ratio (INR). We evaluated the agreement between two INR audit parameters, frequency in range (FIR) and proportion of time in the therapeutic range (TTR), using data from a global population of patients with newly diagnosed non-valvular AF, the Global Anticoagulant Registry in the FIELD\u2013Atrial Fibrillation (GARFIELD-AF). Among 17\ua0168 patients with 1-year follow-up data available at the time of the analysis, 8445 received VKA therapy (\ub1antiplatelet therapy) at enrolment, and of these patients, 5066 with 653 INR readings and for whom both FIR and TTR could be calculated were included in the analysis. In total, 70\ua0905 INRs were analysed. At the patient level, TTR showed higher values than FIR (mean, 56\ub70% vs 49\ub78%; median, 59\ub77% vs 50\ub70%). Although patient-level FIR and TTR values were highly correlated (Pearson correlation coefficient [95% confidence interval; CI], 0\ub7860 [0\ub7852\u20130\ub7867]), estimates from individuals showed widespread disagreement and variability (Lin's concordance coefficient [95% CI], 0\ub7829 [0\ub7821\u20130\ub7837]). The difference between FIR and TTR explained 17\ub74% of the total variability of measurements. These results suggest that FIR and TTR are not equivalent and cannot be used interchangeably

Cardiovascular and renal outcomes with empagliflozin in heart failure

BACKGROUND Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes. More evidence is needed regarding the effects of these drugs in patients across the broad spectrum of heart failure, including those with a markedly reduced ejection fraction. METHODS In this double-blind trial, we randomly assigned 3730 patients with class II, III, or IV heart failure and an ejection fraction of 40% or less to receive empagliflozin (10 mg once daily) or placebo, in addition to recommended therapy. The primary outcome was a composite of cardiovascular death or hospitalization for worsening heart failure. RESULTS During a median of 16 months, a primary outcome event occurred in 361 of 1863 patients (19.4%) in the empagliflozin group and in 462 of 1867 patients (24.7%) in the placebo group (hazard ratio for cardiovascular death or hospitalization for heart failure, 0.75; 95% confidence interval [CI], 0.65 to 0.86; P&lt;0.001). The effect of empagliflozin on the primary outcome was consistent in patients regardless of the presence or absence of diabetes. The total number of hospitalizations for heart failure was lower in the empagliflozin group than in the placebo group (hazard ratio, 0.70; 95% CI, 0.58 to 0.85; P&lt;0.001). The annual rate of decline in the estimated glomerular filtration rate was slower in the empagliflozin group than in the placebo group (-0.55 vs. -2.28 ml per minute per 1.73 m2 of body-surface area per year, P&lt;0.001), and empagliflozin-treated patients had a lower risk of serious renal outcomes. Uncomplicated genital tract infection was reported more frequently with empagliflozin. CONCLUSIONS Among patients receiving recommended therapy for heart failure, those in the empagliflozin group had a lower risk of cardiovascular death or hospitalization for heart failure than those in the placebo group, regardless of the presence or absence of diabetes